These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1305815)

  • 1. Interaction of respiratory syncytial virus with human cord blood mononuclear cells.
    Kositanont U; Vuddhakul V; Kositanont C; Thong YH
    Asian Pac J Allergy Immunol; 1992 Dec; 10(2):135-9. PubMed ID: 1305815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo.
    Domurat F; Roberts NJ; Walsh EE; Dagan R
    J Infect Dis; 1985 Nov; 152(5):895-902. PubMed ID: 2931491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
    Chiba Y; Higashidate Y; Suga K; Honjo K; Tsutsumi H; Ogra PL
    J Med Virol; 1989 Jul; 28(3):133-9. PubMed ID: 2666570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious respiratory syncytial virus (RSV) effectively inhibits the proliferative T cell response to inactivated RSV in vitro.
    Preston FM; Beier PL; Pope JH
    J Infect Dis; 1992 May; 165(5):819-25. PubMed ID: 1373752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human peripheral blood effector cells mediating antibody-dependent cell-mediated cytotoxicity against respiratory syncytial virus.
    Okabe N; Hashimoto G; Abo T; Wright PF; Karzon DT
    Clin Immunol Immunopathol; 1983 May; 27(2):200-9. PubMed ID: 6603313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Respiratory syncytial virus and immune response: from the diagnosis of infection to prospects of vaccination].
    Pothier P
    Pediatrie; 1991; 46(8-9 Suppl):1-4. PubMed ID: 1665219
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages.
    Midulla F; Huang YT; Gilbert IA; Cirino NM; McFadden ER; Panuska JR
    Am Rev Respir Dis; 1989 Sep; 140(3):771-7. PubMed ID: 2476959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].
    Streckert HJ; Humbert B; Philippou S; Forster J
    Immun Infekt; 1993 Jun; 21(3):75-7. PubMed ID: 8335338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of in vitro production of mucosal antibody to respiratory syncytial virus in tonsillar tissue lymphocytes.
    Okamoto Y; Brodsky L; Bernstein JM; Ogra PL
    Clin Immunol Immunopathol; 1988 Nov; 49(2):299-307. PubMed ID: 2458875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection.
    Anderson JJ; Norden J; Saunders D; Toms GL; Scott R
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1561-70. PubMed ID: 2197371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line.
    Ananaba GA; Anderson LJ
    J Virol; 1991 Sep; 65(9):5052-60. PubMed ID: 1870211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to respiratory syncytial virus: prevention of syncytia formation by human serum during in vitro infection.
    Faden H; Lin T; Hong JJ; Ogra PL
    Pediatr Res; 1984 Oct; 18(10):987-91. PubMed ID: 6387611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of cell-mediated cytotoxic activity in the respiratory tract after experimental infection with respiratory syncytial virus.
    Kumagai T; Wong DT; Ogra PL
    Clin Exp Immunol; 1985 Aug; 61(2):351-9. PubMed ID: 3899431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 inhibitor production by human mononuclear leukocytes and leukocyte subpopulations exposed to respiratory syncytial virus: analysis and comparison with the response to influenza virus.
    McCarthy DO; Domurat FM; Nichols JE; Roberts NJ
    J Leukoc Biol; 1989 Sep; 46(3):189-98. PubMed ID: 2788203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV).
    Kaul TN; Faden H; Baker R; Ogra PL
    Clin Exp Immunol; 1984 Jun; 56(3):501-8. PubMed ID: 6744659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.
    Isaacs D; Bangham CR; McMichael AJ
    Lancet; 1987 Oct; 2(8562):769-71. PubMed ID: 2888988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.
    Graham BS; Bunton LA; Wright PF; Karzon DT
    J Clin Invest; 1991 Sep; 88(3):1026-33. PubMed ID: 1909350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune response to respiratory syncytial virus infection in owl monkeys.
    Koff WC; Caplan FR; Case S; Halstead SB
    Clin Exp Immunol; 1983 Aug; 53(2):272-80. PubMed ID: 6883807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of immunosuppression by bovine respiratory syncytial virus.
    Woldehiwet Z; Sharma R
    Scand J Immunol Suppl; 1992; 11():75-80. PubMed ID: 1514055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.